Skip to main content

Complications of Early Pregnancy and Gestational Trophoblastic Diseases

  • Chapter
  • First Online:
Gynecologic and Obstetric Pathology, Volume 2

Abstract

Placenta plays a crucial role in the development of the fetus. By connecting the fetus to the maternal circulation, it allows provision of oxygen and nutrients to the fetus while removing carbon dioxide and metabolic wastes. The placenta also provides essential hormones for the pregnancy and enables immunological protection for the fetus against infection and rejection by the maternal immune system. In this chapter, pathology of abortions as well as gestational trophoblastic diseases is discussed. Gestational trophoblastic diseases encompass a family of aggressive neoplasms, nonneoplastic lesions, and lesions with malignant potential that arise from various types of placental trophoblasts and may pose challenging problems in differential diagnoses in daily pathology practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moore KL, Persaud TVN, Torchia MG. Before we are born : essentials of embryology and birth defects. Philadelphia, PA: Elsevier/Saunders; 2016.

    Google Scholar 

  2. Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In: Fox H, Wells M, editors. Haines & Taylor obstetrical and gynaecological pathology. Edinburgh: Churchill Livingstone; 2003. p. 1359–430.

    Google Scholar 

  3. Shih IM, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesions. In: Kurman R, editor. Blaustein’s pathology of the female genital tract. New York: Springer Verlag; 2002.

    Google Scholar 

  4. Cheung A. Gestational trophoblastic disease. In: Robboy S, Mutter G, Prat J, Bentley R, Russell P, Anderson M, editors. Robboy’s pathology of the female reproductive tract. China: Elsevier Churchill Livingstone; 2009. p. 881–907.

    Chapter  Google Scholar 

  5. Lage JM. Gestational trophoblastic diseases. In: Robbey S, Russel R, editors. Pathology of the female reproductive tract. London: Elsevier; 2001.

    Google Scholar 

  6. Lee CQ, Gardner L, Turco M, Zhao N, Murray MJ, Coleman N, Rossant J, Hemberger M, Moffett A. What is trophoblast? A combination of criteria define human first-trimester trophoblast. Stem Cell Rep. 2016;6:257–72. https://doi.org/10.1016/j.stemcr.2016.01.006.

    Article  CAS  Google Scholar 

  7. Mittal K, Soslow R, McCluggage WG. Application of immunohistochemistry to gynecologic pathology. Arch Pathol Lab Med. 2008;132:402–23. https://doi.org/10.1043/1543-2165(2008)132[402:aoitgp]2.0.co;2.

    Article  PubMed  Google Scholar 

  8. Xue WC, Khoo US, Ngan HY, Chan KY, Ip PP, Tsao SW, Cheung AN. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions. Int J Gynecol Pathol. 2004;23:145–50.

    Article  PubMed  Google Scholar 

  9. Zhang HJ, Xue WC, Siu MK, Liao XY, Ngan HY, Cheung AN. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics. Int J Gynecol Pathol. 2009;28(2):172–8. https://doi.org/10.1097/PGP.0b013e318189555b.

    Article  PubMed  Google Scholar 

  10. Singer G, Kurman RJ, McMaster MT, Shih Ie M. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol. 2002;26:914–20.

    Article  PubMed  Google Scholar 

  11. Shih IM, Nesbit M, Herlyn M, Kurman RJ. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Mod Pathol. 1998;11:1098–106.

    CAS  PubMed  Google Scholar 

  12. Mao TL, Kurman RJ, Jeng YM, Huang W, Shih Ie M. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Am J Surg Pathol. 2008;32:236–42. https://doi.org/10.1097/PAS.0b013e31812e0046.

    Article  PubMed  Google Scholar 

  13. Shih Ie M. Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Ann Diagn Pathol. 2007;11:228–34. https://doi.org/10.1016/j.anndiagpath.2007.04.001.

    Article  PubMed  Google Scholar 

  14. Xue WC, Cheung AN. Complications of early pregnancy, including trophoblastic neoplasia. In: Zheng W, editor. Pathology of obstetrics and gynaecology; 2010.

    Google Scholar 

  15. Royal College of Obstetricians and Gynecologists (2011) The investigation and treatment of couples with recurrent first trimester and second-trimester miscarriage. Green-top Guideline No. 17.

    Google Scholar 

  16. Messaed C, Chebaro W, Di Roberto RB, Rittore C, Cheung A, Arseneau J, Schneider A, Chen MF, Bernishke K, Surti U, Hoffner L, Sauthier P, Buckett W, Qian J, Lau NM, Bagga R, Engert JC, Coullin P, Touitou I, Slim R. NLRP7 in the spectrum of reproductive wastage: rare non-synonymous variants confer genetic susceptibility to recurrent reproductive wastage. J Med Genet. 2011;48:540–8. https://doi.org/10.1136/jmg.2011.089144.

    Article  CAS  PubMed  Google Scholar 

  17. Slim R, Ao A, Surti U, Zhang L, Hoffner L, Arseneau J, Cheung A, Chebaro W, Wischmeijer A. Recurrent triploid and dispermic conceptions in patients with NLRP7 mutations. Placenta. 2011;32:409–12. https://doi.org/10.1016/j.placenta.2011.02.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, Bagga R, Kircheisen R, Ao A, Ratti B, Hanash S, Rouleau GA, Slim R. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 2006;38:300–2. https://doi.org/10.1038/ng1740.

    Article  CAS  PubMed  Google Scholar 

  19. Bouyer J, Coste J, Shojaei T, Pouly JL, Fernandez H, Gerbaud L, Job-Spira N. Risk factors for ectopic pregnancy: a comprehensive analysis based on a large case-control, population-based study in France. Am J Epidemiol. 2003;157:185–94.

    Article  PubMed  Google Scholar 

  20. Fernandez H, Gervaise A. Ectopic pregnancies after infertility treatment: modern diagnosis and therapeutic strategy. Hum Reprod Update. 2004;10:503–13. https://doi.org/10.1093/humupd/dmh043.

    Article  PubMed  Google Scholar 

  21. Zhang Y, Chen J, Lu W, Li B, Du G, Wan X. Clinical characteristics of persistent ectopic pregnancy after salpingostomy and influence on ongoing pregnancy. J Obstet Gynaecol Res. 2017;43:564–70. https://doi.org/10.1111/jog.13251.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Burton JL, Lidbury EA, Gillespie AM, Tidy JA, Smith O, Lawry J, Hancock BW, Wells M. Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy. Histopathology. 2001;38:409–17.

    Article  CAS  PubMed  Google Scholar 

  23. Sebire NJ, Lindsay I, Fisher RA, Savage P, Seckl MJ. Overdiagnosis of complete and partial hydatidiform mole in tubal ectopic pregnancies. Int J Gynecol Pathol. 2005;24:260–4.

    Article  CAS  PubMed  Google Scholar 

  24. Hui P, Baergen RN, Cheung AN, Fukunaga M, Gersell DJ, Lage JM, Ronnett BM, Sebire NJ, Wells M. Gestational trophoblastic disease. In: Kurman RJ, Young RH, Carcangiu ML, Herrington S, editors. In: WHO classification of tumours of female reproductive organs. 4th ed. Lyon: IARC; 2014. p. 155.

    Google Scholar 

  25. Clement P, Young R. Trophoblastic lesions, miscellaneous primary uterine neoplasms, hematopoietic neoplasms, and metastatic neoplasms to the uterus. In: Clement P, Young R, editors. Atlas of gynecologic surgical pathology. 3rd ed. Philadelphia: Saunders; 2013.

    Google Scholar 

  26. Ngan HY, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2015;131(Suppl 2):S123–6. https://doi.org/10.1016/j.ijgo.2015.06.008.

    Article  PubMed  Google Scholar 

  27. Atrash HK, Hogue CJ, Grimes DA. Epidemiology of hydatidiform mole during early gestation. Am J Obstet Gynecol. 1986;154:906–9.

    Article  CAS  PubMed  Google Scholar 

  28. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973–83. Lancet. 1986;2:673–7.

    Article  CAS  PubMed  Google Scholar 

  29. Buckley JD. The epidemiology of molar pregnancy and choriocarcinoma. Clin Obstet Gynecol. 1984;27:153–9.

    Article  CAS  PubMed  Google Scholar 

  30. Hayashi K, Bracken MB, Freeman DH Jr, Hellenbrand K. Hydatidiform mole in the United States (1970–1977): a statistical and theoretical analysis. Am J Epidemiol. 1982;115:67–77.

    Article  CAS  PubMed  Google Scholar 

  31. Ngan HY, Kohorn EI, Cole LA, Kurman RJ, Kim SJ, Lurain JR, Seckl MJ, Sasaki S, Soper JT. Trophoblastic disease. Int J Gynaecol Obstet. 2012;119(Suppl 2):S130–6. https://doi.org/10.1016/S0020-7292(12)60026-5.

    Article  PubMed  Google Scholar 

  32. Ngan HY, Tam KF, Lam KW, Chan KK. Relapsed gestational trophoblastic neoplasia: a 20-year experience. J Reprod Med. 2006;51:829–34.

    PubMed  Google Scholar 

  33. Hando T, Ohno M, Kurose T. Recent aspects of gestational trophoblastic disease in Japan. Int J Gynaecol Obstet. 1998;60(Suppl 1):S71–6.

    Article  PubMed  Google Scholar 

  34. Kim JH, Park DC, Bae SN, Namkoong SE, Kim SJ. Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol. 1998;71:108–12. https://doi.org/10.1006/gyno.1998.5167.

    Article  CAS  PubMed  Google Scholar 

  35. Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4:670–8.

    Article  PubMed  Google Scholar 

  36. Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med. 1994;39:155–62.

    CAS  PubMed  Google Scholar 

  37. Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203:531–9. https://doi.org/10.1016/j.ajog.2010.06.073.

    Article  PubMed  Google Scholar 

  38. La Vecchia C, Parazzini F, Decarli A, Franceschi S, Fasoli M, Favalli G, Negri E, Pampallona S. Age of parents and risk of gestational trophoblastic disease. J Natl Cancer Inst. 1984;73:639–42.

    PubMed  Google Scholar 

  39. Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG. 2002;109:99–102.

    Article  CAS  PubMed  Google Scholar 

  40. Matsuura J, Chiu D, Jacobs PA, Szulman AE. Complete hydatidiform mole in Hawaii: an epidemiological study. Genet Epidemiol. 1984;1:271–84. https://doi.org/10.1002/gepi.1370010306.

    Article  CAS  PubMed  Google Scholar 

  41. Martin PM. High frequency of hydatidiform mole in native Alaskans. Int J Gynaecol Obstet. 1978;15:395–6.

    Article  CAS  PubMed  Google Scholar 

  42. Cheung A. Gestational trophoblastic diseases. In: Ho F, Wu P, editors. Topics in pathology for Hong Kong. Hong Kong: Hong Kong University Press; 1995. p. 147–63.

    Google Scholar 

  43. Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades. A Korean experience. J Reprod Med. 1998;43:60–8.

    CAS  PubMed  Google Scholar 

  44. Kajii T, Ohama K. Androgenetic origin of hydatidiform mole. Nature. 1977;268:633–4.

    Article  CAS  PubMed  Google Scholar 

  45. Lawler SD, Povey S, Fisher RA, Pickthall VJ. Genetic studies on hydatidiform moles. II. The origin of complete moles. Ann Hum Genet. 1982;46:209–22.

    Article  CAS  PubMed  Google Scholar 

  46. Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology. 1996;28:101–10.

    Article  CAS  PubMed  Google Scholar 

  47. Szulman AE. Syndromes of hydatidiform moles. Partial vs. complete. J Reprod Med. 1984;29:788–91.

    CAS  PubMed  Google Scholar 

  48. Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS. Gestational trophoblastic disease. Clin Obstet Gynecol. 2007;50:112–22. https://doi.org/10.1097/GRF.0b013e31802f17fc.

    Article  PubMed  Google Scholar 

  49. Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examination. Ultrasound Obstet Gynecol. 2007;29:76–80. https://doi.org/10.1002/uog.3880.

    Article  CAS  PubMed  Google Scholar 

  50. Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med. 1996;335:1740–8. https://doi.org/10.1056/NEJM199612053352306.

    Article  CAS  PubMed  Google Scholar 

  51. Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Engl J Med. 2009;360:1639–45. https://doi.org/10.1056/NEJMcp0900696.

    Article  CAS  PubMed  Google Scholar 

  52. Baergen RN, Kelly T, McGinniss MJ, Jones OW, Benirschke K. Complete hydatidiform mole with a coexistent embryo. Hum Pathol. 1996;27:731–4.

    Article  CAS  PubMed  Google Scholar 

  53. Keep D, Zaragoza MV, Hassold T, Redline RW. Very early complete hydatidiform mole. Hum Pathol. 1996;27:708–13.

    Article  CAS  PubMed  Google Scholar 

  54. Sebire NJ, Fisher RA, Rees HC. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediatr Dev Pathol. 2003;6:69–77. https://doi.org/10.1007/s10024-002-0079-9.

    Article  PubMed  Google Scholar 

  55. Kim KR, Park BH, Hong YO, Kwon HC, Robboy SJ. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta. Am J Surg Pathol. 2009;33:176–85. https://doi.org/10.1097/PAS.0b013e31817fada1.

    Article  PubMed  Google Scholar 

  56. Kim MJ, Kim KR, Ro JY, Lage JM, Lee HI. Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods. Am J Surg Pathol. 2006;30:362–9. https://doi.org/10.1097/01.pas.0000194299.27463.21.

    Article  CAS  PubMed  Google Scholar 

  57. LeGallo RD, Stelow EB, Ramirez NC, Atkins KA. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization. Am J Clin Pathol. 2008;129:749–55. https://doi.org/10.1309/7XRL378C22W7APBT.

    Article  PubMed  Google Scholar 

  58. McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett BM. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol. 2009;33:805–17. https://doi.org/10.1097/PAS.0b013e318191f309.

    Article  PubMed  Google Scholar 

  59. Banet N, DeScipio C, Murphy KM, Beierl K, Adams E, Vang R, Ronnett BM. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol. 2014;27:238–54. https://doi.org/10.1038/modpathol.2013.143.

    Article  CAS  PubMed  Google Scholar 

  60. Lewis GH, DeScipio C, Murphy KM, Haley L, Beierl K, Mosier S, Tandy S, Cohen DS, Lytwyn A, Elit L, Vang R, Ronnett BM. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Int J Gynecol Pathol. 2013;32:199–214. https://doi.org/10.1097/PGP.0b013e3182630d8c.

    Article  CAS  PubMed  Google Scholar 

  61. Ronnett BM, DeScipio C, Murphy KM. Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol. 2011;30:101–16. https://doi.org/10.1097/PGP.0b013e3181f4de77.

    Article  PubMed  Google Scholar 

  62. Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY, Cheung AN. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol. 2008;173:1165–72. https://doi.org/10.2353/ajpath.2008.080288.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Shih Ie M, Kuo KT. Power of the eternal youth: Nanog expression in the gestational choriocarcinoma. Am J Pathol. 2008;173:911–4. https://doi.org/10.2353/ajpath.2008.080624.

    Article  CAS  PubMed  Google Scholar 

  64. Chiu PM, Liu VW, Ngan HY, Khoo US, Cheung AN. Detection of mitochondrial DNA mutations in gestational trophoblastic disease. Hum Mutat. 2003;22:177. https://doi.org/10.1002/humu.9160.

    Article  CAS  PubMed  Google Scholar 

  65. Murphy KM, Descipio C, Wagenfuehr J, Tandy S, Mabray J, Beierl K, Micetich K, Libby AL, Ronnett BM. Tetraploid partial hydatidiform mole: a case report and review of the literature. Int J Gynecol Pathol. 2012;31:73–9. https://doi.org/10.1097/PGP.0b013e31822555b3.

    Article  PubMed  Google Scholar 

  66. Lipata F, Parkash V, Talmor M, Bell S, Chen S, Maric V, Hui P. Precise DNA genotyping diagnosis of hydatidiform mole. Obstet Gynecol. 2010;115:784–94. https://doi.org/10.1097/AOG.0b013e3181d489ec.

    Article  PubMed  Google Scholar 

  67. Fukunaga M, Endo Y, Ushigome S. Clinicopathologic study of tetraploid hydropic villous tissues. Arch Pathol Lab Med. 1996;120:569–72.

    CAS  PubMed  Google Scholar 

  68. Brown L, Mount S, Reddy R, Slim R, Wong C, Jobanputra V, Clifford P, Merrill L, Brown S. Recurrent pregnancy loss in a woman with NLRP7 mutation: not all molar pregnancies can be easily classified as either “partial” or “complete” hydatidiform moles. Int J Gynecol Pathol. 2013;32:399–405. https://doi.org/10.1097/PGP.0b013e31826cbf6a.

    Article  PubMed  Google Scholar 

  69. Nguyen NM, Slim R. Genetics and epigenetics of recurrent hydatidiform moles: basic science and genetic counselling. Curr Obstet Gynecol Rep. 2014;3:55–64. https://doi.org/10.1007/s13669-013-0076-1.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Nguyen NM, Zhang L, Reddy R, Dery C, Arseneau J, Cheung A, Surti U, Hoffner L, Seoud M, Zaatari G, Bagga R, Srinivasan R, Coullin P, Ao A, Slim R. Comprehensive genotype-phenotype correlations between NLRP7 mutations and the balance between embryonic tissue differentiation and trophoblastic proliferation. J Med Genet. 2014;51:623–34. https://doi.org/10.1136/jmedgenet-2014-102546.

    Article  PubMed  Google Scholar 

  71. Nguyen N, Khawajkie Y, Mechtouf N, Sauthier P, Arseneau J, Rahimi K, Breguet M and Slim R (2017) The genetics of recurrent hydatidiform moles: new findings and lessons from the analysis of 111 patients. XIX Biannual World Congress, International Society of Study of Trophoblastic Diseases, Amsterdam.

    Google Scholar 

  72. Buza N, Hui P. Partial hydatidiform mole: histologic parameters in correlation with DNA genotyping. Int J Gynecol Pathol. 2013;32:307–15. https://doi.org/10.1097/PGP.0b013e3182626011.

    Article  PubMed  Google Scholar 

  73. Chew SH, Perlman EJ, Williams R, Kurman RJ, Ronnett BM. Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM). Hum Pathol. 2000;31:914–24. https://doi.org/10.1053/hupa.2000.9085.

    Article  CAS  PubMed  Google Scholar 

  74. Sebire NJ, May PC, Kaur B, Seckl MJ, Fisher RA. Abnormal villous morphology mimicking a hydatidiform mole associated with paternal trisomy of chromosomes 3,7,8 and unipaternal disomy of chromosome 11. Diagn Pathol. 2016;11:20. https://doi.org/10.1186/s13000-016-0471-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Genest DR. Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol. 2001;20:315–22.

    Article  CAS  PubMed  Google Scholar 

  76. Paradinas FJ, Sebire NJ, Fisher RA, Rees HC, Foskett M, Seckl MJ, Newlands ES. Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology. 2001;39:447–54.

    Article  CAS  PubMed  Google Scholar 

  77. Niemann I, Petersen LK, Hansen ES, Sunde L. Predictors of low risk of persistent trophoblastic disease in molar pregnancies. Obstet Gynecol. 2006;107:1006–11. https://doi.org/10.1097/01.AOG.0000210635.24543.3b.

    Article  PubMed  Google Scholar 

  78. Yeung C-W, Cheung ANY. Negative pregnancy test in patients with trophoblastic diseases. Curr Obstet Gynecol Rep. 2014;3:102–6. https://doi.org/10.1007/s13669-013-0067-2.

    Article  Google Scholar 

  79. Baasanjav B, Usui H, Kihara M, Kaku H, Nakada E, Tate S, Mitsuhashi A, Matsui H, Shozu M. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Hum Reprod. 2010;25:1183–91. https://doi.org/10.1093/humrep/deq052.

    Article  CAS  PubMed  Google Scholar 

  80. Matsui H, Iizuka Y, Sekiya S. Incidence of invasive mole and choriocarcinoma following partial hydatidiform mole. Int J Gynaecol Obstet. 1996;53:63–4.

    Article  CAS  PubMed  Google Scholar 

  81. Agarwal R, Teoh S, Short D, Harvey R, Savage PM, Seckl MJ. Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study. Lancet. 2012;379:130–5. https://doi.org/10.1016/s0140-6736(11)61265-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Cheung AN, Chan KK. Perplexing hCG profile after evacuation of hydatidiform mole. Lancet. 2012;379:98–100. https://doi.org/10.1016/s0140-6736(11)61518-3.

    Article  PubMed  Google Scholar 

  83. Garrett LA, Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med. 2008;53:481–6.

    PubMed  Google Scholar 

  84. Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG. 2003;110:22–6.

    Article  CAS  PubMed  Google Scholar 

  85. Hui P, Martel M, Parkash V. Gestational trophoblastic diseases: recent advances in histopathologic diagnosis and related genetic aspects. Adv Anat Pathol. 2005;12:116–25.

    Article  PubMed  Google Scholar 

  86. Lawler SD, Fisher RA, Pickthall VJ, Povey S, Evans MW. Genetic studies on hydatidiform moles. I. The origin of partial moles. Cancer Genet Cytogenet. 1982;5:309–20.

    Article  CAS  PubMed  Google Scholar 

  87. Jauniaux E. Partial moles: from postnatal to prenatal diagnosis. Placenta. 1999;20:379–88. https://doi.org/10.1053/plac.1999.0390.

    Article  CAS  PubMed  Google Scholar 

  88. Fine C, Bundy AL, Berkowitz RS, Boswell SB, Berezin AF, Doubilet PM. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol. 1989;73:414–8.

    CAS  PubMed  Google Scholar 

  89. Jacobs PA, Szulman AE, Funkhouser J, Matsuura JS, Wilson CC. Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet. 1982;46:223–31.

    Article  CAS  PubMed  Google Scholar 

  90. Sundvall L, Lund H, Niemann I, Jensen UB, Bolund L, Sunde L. Tetraploidy in hydatidiform moles. Hum Reprod. 2013;28:2010–20. https://doi.org/10.1093/humrep/det132.

    Article  CAS  PubMed  Google Scholar 

  91. Golubovsky MD. Postzygotic diploidization of triploids as a source of unusual cases of mosaicism, chimerism and twinning. Hum Reprod. 2003;18:236–42.

    Article  CAS  PubMed  Google Scholar 

  92. Schammel DP, Bocklage T. p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study. Int J Gynecol Pathol. 1996;15:158–66.

    Article  CAS  PubMed  Google Scholar 

  93. Bifulco C, Johnson C, Hao L, Kermalli H, Bell S, Hui P. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol. 2008;32:445–51. https://doi.org/10.1097/PAS.0b013e3181520034.

    Article  PubMed  Google Scholar 

  94. DeScipio C, Haley L, Beierl K, Pandit AP, Murphy KM, Ronnett BM. Diandric triploid hydatidiform mole with loss of maternal chromosome 11. Am J Surg Pathol. 2011;35:1586–91. https://doi.org/10.1097/PAS.0b013e31822d5cff.

    Article  PubMed  Google Scholar 

  95. Rice LW, Berkowitz RS, Lage JM, Goldstein DP, Bernstein MR. Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol. 1990;36:358–62.

    Article  CAS  PubMed  Google Scholar 

  96. Hancock BW, Nazir K, Everard JE. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. J Reprod Med. 2006;51:764–6.

    PubMed  Google Scholar 

  97. Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, Newlands ES. Choriocarcinoma and partial hydatidiform moles. Lancet. 2000;356:36–9. https://doi.org/10.1016/S0140-6736(00)02432-6.

    Article  CAS  PubMed  Google Scholar 

  98. Bynum J, Murphy KM, DeScipio C, Beierl K, Adams E, Anderson D, Vang R, Ronnett BM. Invasive complete hydatidiform moles: analysis of a case series with genotyping. Int J Gynecol Pathol. 2016;35:134–41. https://doi.org/10.1097/PGP.0000000000000232.

    Article  CAS  PubMed  Google Scholar 

  99. Gaber LW, Redline RW, Mostoufi-Zadeh M, Driscoll SG. Invasive partial mole. Am J Clin Pathol. 1986;85:722–4.

    Article  CAS  PubMed  Google Scholar 

  100. Fukunaga M, Katabuchi H, Nagasaka T, Mikami Y, Minamiguchi S, Lage JM. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol. 2005;29:942–7.

    Article  PubMed  Google Scholar 

  101. Ober WB, Edgcomb JH, Price EB Jr. The pathology of choriocarcinoma. Ann N Y Acad Sci. 1971;172:299–426.

    Article  CAS  PubMed  Google Scholar 

  102. Llewellyn-Jones D. Trophoblastic tumors; geographical variations in incidence and possible aetiological factors. J Obstet Gynaecol Br Commonw. 1965;72:242–8.

    Article  CAS  PubMed  Google Scholar 

  103. Shanmugaratnam K, Muir CS, Tow SH, Cheng WC, Christine B, Pedersen E. Rates per 100,000 births and incidence of choriocarcinoma and malignant mole in Singapore Chinese and Malays. Comparison with Connecticut, Norway and Sweden. Int J Cancer. 1971;8:165–75.

    Article  CAS  PubMed  Google Scholar 

  104. Nakano R, Sasaki K, Yamoto M, Hata H. Trophoblastic disease: analysis of 342 patients. Gynecol Obstet Investig. 1980;11:237–42.

    Article  CAS  Google Scholar 

  105. Poen HT, Djojopranoto M. The possible etiologic factors of hydatidiform mole and choriocarcinoma: preliminary report. Am J Obstet Gynecol. 1965;92:510–3.

    Article  CAS  PubMed  Google Scholar 

  106. Brinton LA, Bracken MB, Connelly RR. Choriocarcinoma incidence in the United States. Am J Epidemiol. 1986;123:1094–100.

    Article  CAS  PubMed  Google Scholar 

  107. Ringertz N. Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958–1965. Acta Obstet Gynecol Scand. 1970;49:195–203.

    Article  CAS  PubMed  Google Scholar 

  108. Smith HO. Gestational trophoblastic disease epidemiology and trends. Clin Obstet Gynecol. 2003;46:541–56.

    Article  PubMed  Google Scholar 

  109. Soper JT. Gestational trophoblastic disease. Obstet Gynecol. 2006;108:176–87. https://doi.org/10.1097/01.AOG.0000224697.31138.a1.

    Article  PubMed  Google Scholar 

  110. Smith HO, Kohorn E, Cole LA. Choriocarcinoma and gestational trophoblastic disease. Obstet Gynecol Clin N Am. 2005;32:661–84. https://doi.org/10.1016/j.ogc.2005.08.001.

    Article  Google Scholar 

  111. Lurain JR, Brewer JI, Torok EE, Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol. 1983;145:591–5.

    Article  CAS  PubMed  Google Scholar 

  112. Bagshawe KD, Golding PR, Orr AH. Choriocarcinoma after hydatidiform mole. Studies related to effectiveness of follow-up practice after hydatidiform mole. Br Med J. 1969;3:733–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Jacques SM, Qureshi F, Doss BJ, Munkarah A. Intraplacental choriocarcinoma associated with viable pregnancy: pathologic features and implications for the mother and infant. Pediatr Dev Pathol. 1998;1:380–7.

    Article  CAS  PubMed  Google Scholar 

  114. Sebire NJ, Lindsay I, Fisher RA, Seckl MJ. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma. Fetal Pediatr Pathol. 2005;24:21–9.

    Article  CAS  PubMed  Google Scholar 

  115. Fu Y, Lu W, Zhou C, Xie X. Primary cervical choriocarcinoma: report of four cases and literature review. Int J Gynecol Cancer. 2007;17:715–9. https://doi.org/10.1111/j.1525-1438.2007.00819.x.

    Article  CAS  PubMed  Google Scholar 

  116. Chan DP, Wong WP. Extrauterine gestational choriocarcinoma. Report of two cases. Obstet Gynecol. 1970;35:730–3.

    CAS  PubMed  Google Scholar 

  117. Ober WB, Maier RC. Gestational choriocarcinoma of the fallopian tube. Diagn Gynecol Obstet. 1981;3:213–31.

    CAS  PubMed  Google Scholar 

  118. Mazur MT. Metastatic gestational choriocarcinoma. Unusual pathologic variant following therapy. Cancer. 1989;63:1370–7.

    Article  CAS  PubMed  Google Scholar 

  119. Shen DH, Khoo US, Ngan HY, Ng TY, Chau MT, Xue WC, Cheung AN. Coexisting epithelioid trophoblastic tumor and choriocarcinoma of the uterus following a chemoresistant hydatidiform mole. Arch Pathol Lab Med. 2003;127:e291–3. https://doi.org/10.1043/1543-2165(2003)127<e291:CETTAC>2.0.CO;2.

    Article  PubMed  Google Scholar 

  120. Kalhor N, Ramirez PT, Deavers MT, Malpica A, Silva EG. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol. 2009;33:633–8. https://doi.org/10.1097/PAS.0b013e318191f2eb.

    Article  PubMed  Google Scholar 

  121. Mao TL, Kurman RJ, Huang CC, Lin MC, Shih Ie M. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol. 2007;31:1726–32. https://doi.org/10.1097/PAS.0b013e318058a529.

    Article  PubMed  Google Scholar 

  122. Shih IM, Kurman RJ. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol. 1998;29:27–33.

    Article  CAS  PubMed  Google Scholar 

  123. Shih IM, Kurman RJ. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol. 1999;18:144–50.

    Article  CAS  PubMed  Google Scholar 

  124. Yap KL, Hafez MJ, Mao TL, Kurman RJ, Murphy KM, Shih Ie M. Lack of a y-chromosomal complement in the majority of gestational trophoblastic neoplasms. J Oncol. 2010;2010:364508. https://doi.org/10.1155/2010/364508.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. Rodriguez E, Melamed J, Reuter V, Chaganti RS. Chromosomal abnormalities in choriocarcinomas of the female. Cancer Genet Cytogenet. 1995;80:9–12.

    Article  CAS  PubMed  Google Scholar 

  126. Sheppard DM, Fisher RA, Lawler SD. Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines. Cancer Genet Cytogenet. 1985;16:251–8.

    Article  CAS  PubMed  Google Scholar 

  127. Savage J, Adams E, Veras E, Murphy KM, Ronnett BM. Choriocarcinoma in women: analysis of a case series with genotyping. Am J Surg Pathol. 2017;41:1593–606. https://doi.org/10.1097/pas.0000000000000937.

    Article  PubMed  Google Scholar 

  128. Cheung AN, Zhang HJ, Xue WC, Siu MK. Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives. Future Oncol. 2009;5:217–31. https://doi.org/10.2217/14796694.5.2.217.

    Article  CAS  PubMed  Google Scholar 

  129. Morgan JM, Lurain JR. Gestational trophoblastic neoplasia: an update. Curr Oncol Rep. 2008;10:497–504.

    Article  PubMed  Google Scholar 

  130. Rodabaugh KJ, Bernstein MR, Goldstein DP, Berkowitz RS. Natural history of postterm choriocarcinoma. J Reprod Med. 1998;43:75–80.

    CAS  PubMed  Google Scholar 

  131. Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer. 2001;11:73–7.

    Article  CAS  PubMed  Google Scholar 

  132. Baergen RN, Rutgers JL, Young RH, Osann K, Scully RE. Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol. 2006;100:511–20. https://doi.org/10.1016/j.ygyno.2005.08.058.

    Article  PubMed  Google Scholar 

  133. Hassadia A, Gillespie A, Tidy J, Everard RGNJ, Wells M, Coleman R, Hancock B. Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol. 2005;99:603–7. https://doi.org/10.1016/j.ygyno.2005.06.054.

    Article  PubMed  Google Scholar 

  134. Chang YL, Chang TC, Hsueh S, Huang KG, Wang PN, Liu HP, Soong YK. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. Gynecol Oncol. 1999;73:216–22. https://doi.org/10.1006/gyno.1999.5344.

    Article  CAS  PubMed  Google Scholar 

  135. Scully RE, Young RH. Trophoblastic pseudotumor: a reappraisal. Am J Surg Pathol. 1981;5:75–6.

    Article  CAS  PubMed  Google Scholar 

  136. Young RH, Scully RE. Placental-site trophoblastic tumor: current status. Clin Obstet Gynecol. 1984;27:248–58.

    Article  CAS  PubMed  Google Scholar 

  137. Young RH, Scully RE, McCluskey RT. A distinctive glomerular lesion complicating placental site trophoblastic tumor: report of two cases. Hum Pathol. 1985;16:35–42.

    Article  CAS  PubMed  Google Scholar 

  138. Mazzucco G, Colla L, Monga G. Kidney involvement in a patient affected by placental site trophoblastic tumor. Am J Kidney Dis. 2011;57:516–20. https://doi.org/10.1053/j.ajkd.2010.11.019.

    Article  PubMed  Google Scholar 

  139. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20:31–47.

    Article  CAS  PubMed  Google Scholar 

  140. Hui P, Wang HL, Chu P, Yang B, Huang J, Baergen RN, Sklar J, Yang XJ, Soslow RA. Absence of Y chromosome in human placental site trophoblastic tumor. Mod Pathol. 2007;20:1055–60. https://doi.org/10.1038/modpathol.3800941.

    Article  CAS  PubMed  Google Scholar 

  141. Hui P, Riba A, Pejovic T, Johnson T, Baergen RN, Ward D. Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases. Mod Pathol. 2004;17:248–51. https://doi.org/10.1038/modpathol.3800025.

    Article  CAS  PubMed  Google Scholar 

  142. Hui P, Parkash V, Perkins AS, Carcangiu ML. Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Lab Investig. 2000;80:965–72.

    Article  CAS  PubMed  Google Scholar 

  143. Xue WC, Guan XY, Ngan HY, Shen DH, Khoo US, Cheung AN. Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization. Cancer. 2002;94:2288–94. https://doi.org/10.1002/cncr.10424.

    Article  PubMed  Google Scholar 

  144. Feltmate CM, Genest DR, Wise L, Bernstein MR, Goldstein DP, Berkowitz RS. Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol. 2001;82:415–9. https://doi.org/10.1006/gyno.2001.6265.

    Article  CAS  PubMed  Google Scholar 

  145. Papadopoulos AJ, Foskett M, Seckl MJ, McNeish I, Paradinas FJ, Rees H, Newlands ES. Twenty-five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med. 2002;47:460–4.

    PubMed  Google Scholar 

  146. Finkler NJ. Placental site trophoblastic tumor. Diagnosis, clinical behavior and treatment. J Reprod Med. 1991;36:27–30.

    CAS  PubMed  Google Scholar 

  147. Schmid P, Nagai Y, Agarwal R, Hancock B, Savage PM, Sebire NJ, Lindsay I, Wells M, Fisher RA, Short D, Newlands ES, Wischnewsky MB, Seckl MJ. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet. 2009;374:48–55. https://doi.org/10.1016/S0140-6736(09)60618-8.

    Article  CAS  PubMed  Google Scholar 

  148. Fadare O, Parkash V, Carcangiu ML, Hui P. Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement. Mod Pathol. 2006;19:75–82. https://doi.org/10.1038/modpathol.3800485.

    Article  CAS  PubMed  Google Scholar 

  149. Hamazaki S, Nakamoto S, Okino T, Tsukayama C, Mori M, Taguchi K, Okada S. Epithelioid trophoblastic tumor: morphological and immunohistochemical study of three lung lesions. Hum Pathol. 1999;30:1321–7.

    Article  CAS  PubMed  Google Scholar 

  150. Kuo KT, Chen MJ, Lin MC. Epithelioid trophoblastic tumor of the broad ligament: a case report and review of the literature. Am J Surg Pathol. 2004;28:405–9.

    Article  PubMed  Google Scholar 

  151. Shih IM, Kurman RJ. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol. 1998;22:1393–403.

    Article  CAS  PubMed  Google Scholar 

  152. Palmer JE, Macdonald M, Wells M, Hancock BW, Tidy JA. Epithelioid trophoblastic tumor: a review of the literature. J Reprod Med. 2008;53:465–75.

    CAS  PubMed  Google Scholar 

  153. Meydanli MM, Kucukali T, Usubutun A, Ataoglu O, Kafkasli A. Epithelioid trophoblastic tumor of the endocervix: a case report. Gynecol Oncol. 2002;87:219–24.

    Article  PubMed  Google Scholar 

  154. Cheung AN. Pathology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003;17:849–68.

    Article  PubMed  Google Scholar 

  155. Mao TL, Seidman JD, Kurman RJ, Shih Ie M. Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor—an aid in differential diagnosis. Am J Surg Pathol. 2006;30:1105–10. https://doi.org/10.1097/01.pas.0000209854.28282.87.

    Article  PubMed  Google Scholar 

  156. Shih IM, Kurman RJ. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol. 2004;28:1177–83.

    Article  PubMed  Google Scholar 

  157. Xu ML, Yang B, Carcangiu ML, Hui P. Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping. Mod Pathol. 2009;22:232–8. https://doi.org/10.1038/modpathol.2008.165.

    Article  CAS  PubMed  Google Scholar 

  158. Tsai HW, Lin CP, Chou CY, Li CF, Chow NH, Shih IM, Ho CL. Placental site nodule transformed into a malignant epithelioid trophoblastic tumour with pelvic lymph node and lung metastasis. Histopathology. 2008;53:601–4. https://doi.org/10.1111/j.1365-2559.2008.03145.x.

    Article  PubMed  Google Scholar 

  159. Lewin SN, Aghajanian C, Moreira AL, Soslow RA. Extrauterine epithelioid trophoblastic tumors presenting as primary lung carcinomas: morphologic and immunohistochemical features to resolve a diagnostic dilemma. Am J Surg Pathol. 2009;33:1809–14. https://doi.org/10.1097/PAS.0b013e3181b9cd67.

    Article  PubMed  Google Scholar 

  160. Narita F, Takeuchi K, Hamana S, Ohbayashi C, Ayata M, Maruo T. Epithelioid trophoblastic tumor (ETT) initially interpreted as cervical cancer. Int J Gynecol Cancer. 2003;13:551–4.

    Article  CAS  PubMed  Google Scholar 

  161. Deavers MT, Kalhor N, Silva EG. Diagnostic problems with trophoblastic lesions. Arch Pathol Lab Med. 2008;132:168–74. https://doi.org/10.1043/1543-2165(2008)132[168:DPWTL]2.0.CO;2.

    Article  PubMed  Google Scholar 

  162. Lurain JR. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol. 2011;204:11–8. https://doi.org/10.1016/j.ajog.2010.06.072.

    Article  PubMed  Google Scholar 

  163. Young RH, Kurman RJ, Scully RE. Proliferations and tumors of intermediate trophoblast of the placental site. Semin Diagn Pathol. 1988;5:223–37.

    CAS  PubMed  Google Scholar 

  164. Wan SK, Lam PW, Pau MY, Chan JK. Multiclefted nuclei. A helpful feature for identification of intermediate trophoblastic cells in uterine curetting specimens. Am J Surg Pathol. 1992;16:1226–32.

    Article  CAS  PubMed  Google Scholar 

  165. Yeh IT, O'Connor DM, Kurman RJ. Intermediate trophoblast: further immunocytochemical characterization. Mod Pathol. 1990;3:282–7.

    CAS  PubMed  Google Scholar 

  166. Dotto J, Hui P. Lack of genetic association between exaggerated placental site reaction and placental site trophoblastic tumor. Int J Gynecol Pathol. 2008;27:562–7. https://doi.org/10.1097/PGP.0b013e31816d1d00.

    Article  PubMed  Google Scholar 

  167. Young RH, Kurman RJ, Scully RE. Placental site nodules and plaques. A clinicopathologic analysis of 20 cases. Am J Surg Pathol. 1990;14:1001–9.

    Article  CAS  PubMed  Google Scholar 

  168. Huettner PC, Gersell DJ. Placental site nodule: a clinicopathologic study of 38 cases. Int J Gynecol Pathol. 1994;13:191–8.

    Article  CAS  PubMed  Google Scholar 

  169. Shih IM, Seidman JD, Kurman RJ. Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol. 1999;30:687–94.

    Article  CAS  PubMed  Google Scholar 

  170. Shitabata PK, Rutgers JL. The placental site nodule: an immunohistochemical study. Hum Pathol. 1994;25:1295–301.

    Article  CAS  PubMed  Google Scholar 

  171. Chen BJ, Cheng CJ, Chen WY. Transformation of a post-cesarean section placental site nodule into a coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor: a case report. Diagn Pathol. 2013;8:85. https://doi.org/10.1186/1746-1596-8-85.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Annie N. Y. Cheung .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Science Press & Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ip, P.P.C., Wang, Y., Cheung, A.N.Y. (2019). Complications of Early Pregnancy and Gestational Trophoblastic Diseases. In: Zheng, W., Fadare, O., Quick, C., Shen, D., Guo, D. (eds) Gynecologic and Obstetric Pathology, Volume 2. Springer, Singapore. https://doi.org/10.1007/978-981-13-3019-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-3019-3_13

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-3018-6

  • Online ISBN: 978-981-13-3019-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics